Skip to Main Content

Tulane University LaSOR Project ECHO (Extension For Community Healthcare Outcomes)

Addiction Medicine - ECHO connects providers with specialists through ongoing, interactive, tele-mentoring sessions.

Educational opportunities + Forms + Organizations of interest + Contacts

Millie Mattered Advocacy Drug Epidemic Walks   -Outreach & Awareness in LouisianaFacebook page Millie Mattered for more information on my advocacy. You can contact me on Facebook messenger, or email me milliemattered@gmail.com Phone (318)403-2414

More information: Facebook page Millie Mattered  OR milliemattered@gmail.com

Every Step Matters!

LaSOR Project ECHO Sessions are in order of date of presentation, most recent to oldest session

PDF versions of the PowerPoint presentations follow. References and related resources may also be available here.

LaSOR Project ECHO Series 4:June 2024-

LaSOR Project ECHO Series 4: May 2024

LaSOR Project ECHO Series 4: April 2024.

LaSOR Project ECHO Series 4: February 2024 - March 2024

 

"Expanding buprenorphine prescribing: Community and clinician interventions" (March 14, 2024)

 "Post Hospitalization Transition of Care Models for SUD" presented by Dr. Lee Michals. (March 7, 2024)

Series 3: November, 2023-

Series 3: September, 2023.

Series 3: July 2023-August 2023

Series 3: June 2023

Research into the development of a Fentanyl Vaccine | Brainstorming application of a possible Fentanyl Vaccine (June 8, 2023) - Kathryn Germeraad, DO,  Addiction Medicine Fellow, Tulane

Series 3: March 2023- May 2023

Sleep Deficiency and Opioid Use Disorder: Trajectory, Mechanisms, and Interventions) - (May 25, 2023) /  Stephen D. Milhollin, DO MPH , Addiction Medicine Fellow, Tulane

Langstengel J, Yaggi HK. Sleep Deficiency and Opioid Use Disorder: Trajectory, Mechanisms, and Interventions. Clin Chest Med. 2022 Jun;43(2):e1-e14. doi: 10.1016/j.ccm.2022.05.001. PMID: 35659031; PMCID: PMC10018646.
https://pubmed.ncbi.nlm.nih.gov/35659031/

Case study-  Research Chemical and Opioid Use Disorder  (May 11, 2023)
Kathryn Davis Germeraad, DO, Tulane Addiction Medicine Fellow  

Baumann MH, Tocco G, Papsun DM, Mohr AL, Fogarty MF, Krotulski AJ. U-47700 and Its Analogs: Non-Fentanyl Synthetic Opioids Impacting the Recreational Drug Market. Brain Sci. 2020 Nov 23;10(11):895. doi: 10.3390/brainsci10110895. PMID: 33238449; PMCID: PMC7700279.

Series 3: January-February 2023-

Harm Reduction (Fentanyl Strip Use) - (February 23, 2023) /  Dr. Muhammad Basit, Addiction Medicine Fellow, Tulane

Case presentation -   Fentanyl-laced cocaine - Harm reduction using fentanyl strips

 

Series 3: December 2022

 

 

Series 2: October - November 2022.

Series 2: September 2022 -

Series 2: July-August 2022

Series 2 - June 2022-

Series 2 - May 2022

  • What the Fentanyl? / Dr. Limbaugh (May 5, 2022)
  • Microdosing Inductions / Dr. Limbaugh  (May 12, 2022)
  •  Macrodosing Patients /  Dr. Limbaugh  (May 19, 2022)
  • OUD Therapy in Pregnancy   Dr. Limbaugh  (May 26, 2022)

Series 2 - January - March 2022

Series 2 - October-December 2021

Series 2 - July -- September 2021.

Series 2 - June 2021.

Series 2 - March-May 2021 (session slides)

Series 2 - February 2021 (Session Slides)

New Series - 2 - December 2020 (Session Slides) - PDFs

New Series - 2 - November 2020 (Session Slides) - PDFs

Introduction to Medication-Assisted Treatment (MAT) - New Series - 10-8-2020

Stimulants: Sessions (Sept. 2020) / Faculty/Presenter: George Singletary MD MPH

Treatment of Addiction (August 19 & 20, 2020) - Dr. Ken Roy (Part 3)

Some Opioid Agonists You May Not Know, But Your Patients Might. (July 29 & 30, 2020)

Buprenorphine Micro Induction (July 22 and 23, 2020)

An Update on Home induction (July 15 & 16, 2020) / George Singletary

Withdrawal Symptom Management (July 7 & 8, 2020) / George Singletary

An Update on Fentanyl (July 1 & 2, 2020) / George Singletary

Substance Use Disorders in Pregnancy (Series of Sessions, June 2020) / Julianna Finelli, MD

Managing Pain in Patients with OUD (Series of sessions) / Rachel Barenie, PharmD, JD, MPH

HCV - Hepatitis C Virus (April 2020) / Dr.Dr. Brandon Mizroch

Legal Series (March 2020) / Presenter: Daniel C. McClughen, JD, Counsel to Center for U.S. Policy; Associate Attorney, DCBA Law & Policy LLP

Naloxone for Patients with Opioid Use Disorder (Feb.26, 2020)

Selecting a medication to manage Opioid Use Disorder (Feb. 19 & 20, 2020)

Evidence supporting medication use to manage Opioid Use Disorder (Feb.12&13, 2020)

Medications for Opioid Use Disorder (February 5 and 6, 2020)

Buprenorphine Induction (January 29 & 30, 2020)

Anatomy and Neurochemistry of Addiction (Jan. 8 & 9, 2020)

Criminal Justice and OUD (01-02-2020)

Co-Occurring Disorders and Mortality (12-12-2019)

Ethical and Legal Issues in Substance Abuse Treatment (12-19-2019)

Risk Reduction and Safe Use of Opioids (Dec.5, 2019)

Management Opioid Withdrawal and Preventing Overdose ( Part 2)- (11-21-2019)

Pregnancy and OUD (11-7-1219)

Trauma-Informed Care & OUD (10-31-2019)

STIGMA AND OPIOID USE DISORDER (10-10-2019)

Operating a MAT Clinic: The nuts & bolts ( 9/26/2019) - MAT Clinic Process and Workflow

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.